CAMBRIDGE, Mass.–(BUSINESS WIRE)– RaNA Therapeutics, a leader in the discovery and development of a new
class of medicines that target RNA, today announced the company’s CEO,
Ronald Renaud, will present a corporate overview at the UBS Global
Healthcare Conference at 3:00 p.m. ET on Monday, May 22. The conference
will take place at the Grand Hyatt New York.
About RaNA Therapeutics
RaNA Therapeutics is a leading biotechnology company committed to the
development of next generation RNA-targeted medicines. RaNA’s mission is
to improve the lives of people suffering from serious life-altering
diseases by creating precision medicines that can change the course of
their condition. RaNA’s technology has broad therapeutic potential to
treat a wide range of diseases, including rare genetic disorders. For
more information about the company and its platforms, please visit www.ranarx.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170515005097/en/
Source: RaNA Therapeutics
Cet article RaNA Therapeutics to Present at 2017 UBS Global Healthcare Conference est apparu en premier sur EEI-BIOTECHFINANCES.